Targeting protein prenylation for cancer therapy

N Berndt, AD Hamilton, SM Sebti - Nature Reviews Cancer, 2011 - nature.com
Protein farnesylation and geranylgeranylation, together referred to as prenylation, are lipid
post-translational modifications that are required for the transforming activity of many …

Apoptosis in cancer

SW Lowe, AW Lin - Carcinogenesis, 2000 - academic.oup.com
In the last decade, basic cancer research has produced remarkable advances in our
understanding of cancer biology and cancer genetics. Among the most important of these …

Cholesterol and beyond-The role of the mevalonate pathway in cancer biology

A Göbel, M Rauner, LC Hofbauer… - Biochimica et Biophysica …, 2020 - Elsevier
Cancer is a multifaceted global disease. Transformation of a normal to a malignant cell takes
several steps, including somatic mutations, epigenetic alterations, metabolic reprogramming …

Reversible tumorigenesis by MYC in hematopoietic lineages

DW Felsher, JM Bishop - Molecular cell, 1999 - cell.com
The targeted repair of mutant protooncogenes or the inactivation of their gene products may
be a specific and effective therapy for human neoplasia. To examine this possibility, we have …

Ras protein farnesyltransferase: a strategic target for anticancer therapeutic development

EK Rowinsky, JJ Windle, DD Von Hoff - Journal of Clinical Oncology, 1999 - ascopubs.org
Ras proteins are guanine nucleotide–binding proteins that play pivotal roles in the control of
normal and transformed cell growth and are among the most intensively studied proteins of …

Role of farnesyltransferase in ABA regulation of guard cell anion channels and plant water loss

ZM Pei, M Ghassemian, CM Kwak, P McCourt… - Science, 1998 - science.org
Desiccation of plants during drought can be detrimental to agricultural production. The
phytohormone abscisic acid (ABA) reduces water loss by triggering stomatal pore closure in …

Cancer gene therapy: fringe or cutting edge?

F McCormick - Nature Reviews Cancer, 2001 - nature.com
Direct targeting of cancer cells with gene therapy has the potential to treat cancer on the
basis of its molecular characteristics. But although laboratory results have been extremely …

Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

CWM Reuter, MA Morgan… - Blood, The Journal of the …, 2000 - ashpublications.org
A series of alterations in the cellular genome affecting the expression or function of genes
controlling cell growth and differentiation is considered to be the main cause of cancer …

[HTML][HTML] The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3

Y Yu, GS Hayward - Immunity, 2010 - cell.com
In the course of combating infectious agents, type I interferon (IFN) needs a timely
downregulation mechanism to avoid detrimental overreaction. Here we showed a …

Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer

MR Graaf, DJ Richel, CJF van Noorden… - Cancer treatment …, 2004 - Elsevier
Statins (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors–HMG-CoA reductase
inhibitors) have been approved for the treatment of lipid disorders. Recently, in vivo studies …